Literature DB >> 10211627

Fibrinogen gene polymorphism in a non-Caucasian population.

D H Lee1, S H Hong, J Song, W K Min, J Q Kim.   

Abstract

OBJECTIVE: The purpose of this study was to investigate the two polymorphisms of fibrinogen gene (RsaI and MnlI RFLPs in the coding region of the fibrinogen gene) in Koreans, and their relation to plasma fibrinogen.
METHODS: Using PCR-amplified DNAs, RsaI and MnlI RFLPs were analyzed in 112 patients with coronary artery disease (CAD) and 137 healthy subjects. To compare the mean of plasma fibrinogen and lipid levels among different genotypes, one-way analysis of variance (ANOVA) test was performed.
RESULTS: Allele frequencies of fibrinogen gene polymorphism in Koreans were not significantly different between CAD and control groups; fibrinogen polymorphism in this population showed a lack of association with plasma fibrinogen levels, but significant association with BMI (p < 0.05).
CONCLUSION: This evidence suggests that in Korean populations, fibrinogen gene polymorphism is not a factor in the expression of atherosclerosis. There might, however, be an association between fibrinogen gene and obesity in such population.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10211627     DOI: 10.1016/s0009-9120(98)00095-2

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  1 in total

1.  A double-blind, placebo-controlled pilot study to evaluate the effect of calcium fructoborate on systemic inflammation and dyslipidemia markers for middle-aged people with primary osteoarthritis.

Authors:  Romulus Scorei; Paul Mitrut; Iulian Petrisor; Iulia Scorei
Journal:  Biol Trace Elem Res       Date:  2011-05-24       Impact factor: 3.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.